The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings
- 1 February 2000
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 182 (2), 439-442
- https://doi.org/10.1016/s0002-9378(00)70236-5
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- The Preterm Prediction Study: Recurrence risk of spontaneous preterm birthAmerican Journal of Obstetrics and Gynecology, 1998
- The preterm prediction study: Patterns of cervicovaginal fetal fibronectin as predictors of spontaneous preterm deliveryAmerican Journal of Obstetrics and Gynecology, 1997
- Fetal fibronectin as a predictor of preterm birth in patients with symptoms: A multicenter trialAmerican Journal of Obstetrics and Gynecology, 1997
- Use of Fetal Fibronectin in Clinical PracticeObstetrical & Gynecological Survey, 1997
- Rapid fetal fibronectin swab-test in preterm labor patients treated by betamimeticsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1997
- Predictors of positivity for fetal fibronectin in patients with symptoms of preterm laborAmerican Journal of Obstetrics and Gynecology, 1997
- Value of fetal fibronectin as a predictor of preterm delivery for a low-risk populationAmerican Journal of Obstetrics and Gynecology, 1996
- Regulation of fetal fibronectin production in human amnion cellsJournal of the Society for Gynecologic Investigation, 1996
- Fetal Fibronectin in the Cervicovaginal Fluid of Women with Threatened Preterm Labour as a Predictor of Delivery Before 34 Weeks' GestationAustralian and New Zealand Journal of Obstetrics and Gynaecology, 1995
- Oncofetal fibronectin in patients with false labor as a predictor of preterm deliveryAmerican Journal of Obstetrics and Gynecology, 1993